# Captopril

## Ceporin 25mg

##### 

| Title              | Content                                                                                                                                                                                                |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OCEPO                                                                                                                                                                                                  |
| Indications        | Hypertension， chronic heart failure.                                                                                                                                                                  |
| Dosing             | HTN initial 25mg TIDAC slow titrate up Max 450mg/day (Take one hour before meals ) CHF: initial dose of 6.25 or 12.5 mg TID in patients with normal or low blood pressure; maintence dose: -50mg TIDAC |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                          |
| Contraindications  | Pregnancy                                                                                                                                                                                              |
| Adverse Effects    | Dysgeusia， skin rash， cough                                                                                                                                                                          |
| Pregnancy          | Human data suggest risk in 2nd and 3 rd trimesters                                                                                                                                                     |
| Lactation          | Compatible                                                                                                                                                                                             |

